ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) /

The profitability of ARCUTIS BIOTHERAPEUTICS, INC. over the past 8 years

Chart ARCUTIS BIOTHERAPEUTICS, INC.: gross profit, operating income, net income, fiscal 2018–2025 Open the chart →

ARCUTIS BIOTHERAPEUTICS, INC. reported a net loss of $16.14M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $339.38M and an operating loss of $12.23M. It reported a loss in all 8 years shown.

Year by year

Fiscal yearGross profitOperating incomeNet income
2025ended Dec 31, 2025$339.38M*-$12.23M-$16.14M
2024ended Dec 31, 2024$177.41M*-$128.4M-$140.04M
2023ended Dec 31, 2023$54.62M*-$241.1M-$262.14M
2022ended Dec 31, 2022$2.93M*-$301.63M-$311.46M
2021ended Dec 31, 2021$0*-$206.53M-$206.36M
2020ended Dec 31, 2020—-$136.65M-$135.68M
2019ended Dec 31, 2019—-$43.13M-$42M
2018ended Dec 31, 2018—-$19.73M-$19.25M

Fiscal years as ARCUTIS BIOTHERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on ARCUTIS BIOTHERAPEUTICS, INC.

Companies of a similar size

Not investment advice. This page shows what ARCUTIS BIOTHERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.